Ruiying Fu
Overview
Explore the profile of Ruiying Fu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liang X, Guo J, Wang X, Luo B, Fu R, Chen H, et al.
J Natl Cancer Cent
. 2025 Mar;
5(1):57-74.
PMID: 40040873
Background: Previous researches mainly focused on whether cancer stem cells exist in diffuse large B-cell lymphoma (DLBCL). However, subgroups with dismal prognosis and stem cell-like characteristics have been overlooked. Methods:...
2.
Wang L, Fu R, Qi X, Xu J, Li C, Chen C, et al.
ACS Appl Mater Interfaces
. 2024 Sep;
16(39):52663-52673.
PMID: 39305227
The porous carbon materials, namely, MC700/800, PC700/800, and SC700/800, have been prepared using several biomasses (mushroom dreg, Chinese parasol leaves, and leaves) as individual precursors at 700 and 800 °C...
3.
Shan T, Ran X, Li H, Feng G, Zhang S, Zhang X, et al.
J Natl Cancer Cent
. 2024 Jul;
3(1):7-13.
PMID: 39036312
Background: The stage at diagnosis is a major factor in making treatment strategies and cancer control policies. However, the stage distribution for liver cancer in China was not well studied....
4.
Zeng H, Cao M, Xia C, Wang D, Chen K, Zhu Z, et al.
Nat Cancer
. 2023 Sep;
4(9):1396.
PMID: 37697046
No abstract available.
5.
Fu R, Sun K, Wang X, Liu B, Wang T, Morze J, et al.
Lancet Reg Health West Pac
. 2023 Sep;
37:100799.
PMID: 37693879
Background: The systematic comparison of cancer survival between China and the USA is rare. Here we aimed to assess the magnitude of survival disparities and disentangle the impact of the...
6.
Zeng H, Cao M, Xia C, Wang D, Chen K, Zhu Z, et al.
Nat Cancer
. 2023 Sep;
4(9):1382-1394.
PMID: 37667043
Current guidelines recommend hepatocellular carcinoma (HCC) surveillance for at-risk individuals, including individuals with hepatitis B virus infection. However, the performance and survival benefits of annual screening have not been evaluated...
7.
Fu R, Liang Y, Wei L, Liu X, Piao Y, Wang L
Chin Med J (Engl)
. 2023 Mar;
136(6):732-734.
PMID: 36939235
No abstract available.
8.
Zeng H, Yuan C, Morze J, Fu R, Wang K, Wang L, et al.
EBioMedicine
. 2022 Nov;
86:104345.
PMID: 36371990
Background: Limited data indicate that patients with colorectal cancer (CRC) are at higher risk of developing type 2 diabetes (T2D). We prospectively examined the risk of T2D between individuals with...
9.
Chen Y, Ni P, Fu R, Murphy K, Wyeth R, Bishop C, et al.
Ecol Appl
. 2022 Nov;
34(1):e2772.
PMID: 36316814
Elucidating processes and mechanisms involved in rapid local adaptation to varied environments is a poorly understood but crucial component in management of invasive species. Recent studies have proposed that genetic...
10.
Liang Y, He H, Wang W, Wang H, Mo S, Fu R, et al.
Mol Cancer
. 2022 Sep;
21(1):182.
PMID: 36131282
Background: Multiple myeloma (MM) is a heterogeneous disease with different patterns of clonal evolution and a complex tumor microenvironment, representing a challenge for clinicians and pathologists to understand and dissect...